September 13, 2019
HUB Tumor Organoids: Top 15 Questions
Review the key questions on HUB tumor organoids from our recent webinar, answered by Dr Sylvia Boj, Hubrecht Organoid Technology (HUB) Scientific Director.
LEARN MORE
September 11, 2019
HUB Organoids: Top 9 Technical Questions
Review the top 9 technical questions on HUB organoid development from our recent webinar, answered by Dr Sylvia Boj, ...
LEARN MORE
September 10, 2019
How to Assess Immunotherapy Toxicity with NHP Models
How to Assess Immunotherapy Toxicity with NHP Models Explore non-GLP exploratory toxicology NHP studies as a rapid and ...
LEARN MORE
September 4, 2019
Mouse Models of Inflammatory Bowel Disease
Mouse Models of Inflammatory Bowel Disease Review the wide variety of inflammatory bowel disease mouse models ...
LEARN MORE
August 27, 2019
Banana Tolerance Test: A New Stress-Free OGTT Method
Banana Tolerance Test: A New Stress-Free OGTT Method Learn more about the banana tolerance test, which shares ...
LEARN MORE
August 13, 2019
Continuous Glucose Monitoring in NHP Models
Discover continuous glucose monitoring as an enhanced technique for preclinical blood glucose measurement in NHP models ...
LEARN MORE
July 9, 2019
CAR-T Cell Therapy for Pancreatic Cancer
Explore how CAR-T cell therapy is showing promise as a novel treatment strategy for pancreatic cancer.
LEARN MORE
June 11, 2019
Orthotopic or Subcutaneous Tumor Homograft Models?
When should you use either subcutaneous or orthotopic pancreatic cancer tumor homografts, and where do they best ...
LEARN MORE
April 3, 2019
New Analysis, Model ID, and Modeling Technologies at AACR 2019
In Atlanta this week we’re presenting data on our new analysis platforms and preclinical technologies. This post recaps ...
LEARN MORE
April 2, 2019
Syngeneic and Tumor Homograft Immuno-Oncology Models at AACR 2019
Recap all our AACR presentations on murine models including bioluminescent orthotopic syngeneic models, syngeneic model ...
LEARN MORE
April 1, 2019
Humanized Model Update at AACR 2019
Review all the new data on our humanized target models for human-specific CD40 and combination regimen assessment, and how we’re using PBMC and HSC humanized mice to model graft vs host disease.
LEARN MORE
April 1, 2019
AACR19 Analysis: PDX and PDX-Derived Organoid Models
Review all the new data on patient-derived xenograft (PDX) models we’re presenting at AACR 2019 this week, including ...
LEARN MORE
March 6, 2019
Using Genetic Features to ID and QC Murine Tumor Models
Learn how unique genetic events can be used to generate a “genetic fingerprint” to ID and QC murine tumor models.
LEARN MORE
March 1, 2019
Novel Uses for PDX Models in Preclinical Drug Development
Learn how unique PDX models are used to support clinical drug development, discover predictive gene signatures, and for ...
LEARN MORE
February 5, 2019
Beginners Guide to PBMC Humanized Tumor Models
Discover PBMC-humanized tumor models for short-term immunotherapy assessment studies.
LEARN MORE
